The 2012 ACS Cancer Facts & Figures

Yesterday, The American Cancer Society (ACS) released their annual cancer statistics for the United States. Specific to prostate cancer, they indicated an increase in projected new prostate cancer diagnosis, but a decrease in prostate cancer deaths. In 2011, the ACS projected 240,890 new cases of prostate cancer; in 2012 they are projecting 241,740 new diagnoses. [...]

By |2021-02-17T11:03:31-05:00January 5th, 2012|Advanced Prostate Cancer, How We Live, Uncategorized|0 Comments

A Survival Advantage – Is It Worth It and What Does It Mean? When Economics Interface with Survival

In order to get FDA approval, drugs must first go through a clinical trial that demonstrates that they offer a better treatment result than the current standard of care. In some instances the better result can be a demonstration that the investigational drug provides an advantage which is only palliative (as Mitoxantrone does for advance [...]

2010 Statistical Projection of the Death Rate for Prostate Cancer Exceeds the Projection for Breast Cancer

Recent statistics projecting the cancer incidence in the United States for 2010 have a number of interesting items buried inside the data charts. I thought that three items were particularly interesting and relevant, so I want to share them with you. 1- The 2010 expected death rate per 100,000 cases for the "Good Cancer" (prostate [...]

Go to Top